Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on May 27, 2021 11:23am
60 Views
Post# 33275600

RE:RE:RE:RE:This comment from LTF ay be of interest re: NGM

RE:RE:RE:RE:This comment from LTF ay be of interest re: NGMThose conversations reflect the reality fo the hole the company dug for itself, even while pulling two huge pabbits out of the hat (cancer and general NASH) in a big bull market. It will not take too much, however, to get that rebranding process for the stock going and for the past sins to be forgotten, particularly by newer investors. 

PWIB123 wrote: Thank you for the additional clarity there SPCE01.  I remember you or someone else pointing out the potential and even need for combination treatment plans.  I assume in a market this large, there will be plenty of opportunity and even competitive advantages that become evident with time.

I hope new readers on this board can see through the necessary conversations about the reality of where THTX has been while also seeing the potential for what is to come.  Honestly, if I were a new reader, I'm not sure I would see much positive when reading the comments.  I'm not being critical of the conversations.  They are great.  But I'm not sure I would have the confidence to jump in based on the conversations today, without a really solid understanding of how large the potential is.  I wouldn't have that understanding without having been following along for the last couple years.


<< Previous
Bullboard Posts
Next >>